Lucia Masarova

34PUBLICATIONS
96CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Apr 29, 2026
Prevalence, incidence, and risk factors of secondary malignancies in patients with polycythemia vera: a real-world study.

|Apr 08, 2026
A pharmacological profile of pacritinib for the treatment of myelofibrosis.

Hannah Goulart, Lucia Masarova, Naveen Pemmaraju

|Aug 19, 2025
Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase.

Warren Fiskus, Lucia Masarova, Christopher P Mill

|Dec 01, 2024
Ten years of experience with ruxolitinib since approval for polycythemia vera: A review of clinical efficacy and safety.

Lucia Masarova, John Mascarenhas, Raajit Rampal

|Nov 25, 2024
Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia.

Wei-Ying Jen, Jennifer Marvin-Peek, Hagop M Kantarjian

|Nov 19, 2024
Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML.

Warren Fiskus, Christopher P Mill, Prithviraj Bose

Pageof 6

Frequent Collaborators

16 joint publications

Naveen Pemmaraju

14 joint publications

Naval G Daver

13 joint publications

Hagop M Kantarjian

13 joint publications

Koji Sasaki